- ►diabetesjournals.org [PDF] M Ito, D Grujic, ED Abel, A Vidal-Puig, VS Susulic, J … - Diabetes, 1998 - Am Diabetes Assoc 3-Adrenergic receptors (ARs) are expressed predom- inantly in adipose tissue, and 3-selective
agonists are e ffective anti-obesity drugs in rodents. Rodent and human 3-ARs differ with respect to
expression in white versus brown ... Cited by 38 - Related articles - BL Direct - All 4 versions
HGR Elements - DIABETES, 1998 - Am Diabetes Assoc 3 -Adrenergic receptors (ARs) are expressed predom- inantly in adipose tissue, and 3 -selective
agonists are e ffective anti-obesity drugs in rodents. Rodent and human 3 -ARs differ with respect
to expression in white versus brown ... Related articles
PL Thurlby, RDM Ellis - Canadian journal of physiology and …, 1986 - article.pubs.nrc-cnrc.gc.ca Abstract: In mature (450–600 g) 21 °C-acclimated male rats, anaesthetized with urethane, blood
flow (measured by the radioactive microsphere technique) to brown adipose tissue (BAT) was
determined during the infusion of ... Cited by 31 - Related articles - Cached - All 4 versions
- ►nih.gov [PDF] JP Revelli, F Preitner, S Samec, P … - Journal of Clinical …, 1997 - pubmedcentral.nih.gov Targeted disruption of mouse 3-adrenoceptor was gener- ated by homologous recombination, and
validated by an acute in vivo study showing a complete lack of effect of the 3-adrenoceptor agonist
CL 316,243 on the metabolic rate of ... Cited by 71 - Related articles - BL Direct - All 7 versions
F Pietri-Rouxel, AD Strosberg - Fundam Clin Pharmacol, 1995 - interscience.wiley.com Summary—Beta-adrenergic receptors (β/-AR) belong to the large multigenic family of receptors
coupled to GTP-binding proteins. Three subtypes have been identified: β 1 -, β 2 - and β 3 -AR.
Much of the work delineating the ... Cited by 32 - Related articles - All 3 versions
[CITATION] The Contribution of Classical ( ~ 1~/~ 2-) and Atypical -Adrenoceptors to the …
JM Bryson, VR Wensley, JL Phuyal, ID … - … and metabolic research …, 1999 - ncbi.nlm.nih.gov BRL 26830A, a beta adrenoceptor agonist, has been shown to have antiobesity and antidiabetic
properties in rodents. The aim of this study was to study the effects of chronic BRL 26830A
treatment (20 mg/kg/day for 9 ... Cited by 8 - Related articles - BL Direct - All 2 versions
NM Wheeldon, DG McDevitt, LC McFarlane, … - … London, England: 1979 …, 1994 - ncbi.nlm.nih.gov 1. The aim of the present study was to evaluate the metabolic responses produced in man by the beta
3-adrenoceptor agonist BRL 35135, and to determine which of these responses are beta 3-, rather than
beta 1- or beta 2-, mediated. 2. ... Cited by 20 - Related articles - BL Direct - All 8 versions
